Testosterone Treatment Lawsuit News: FDA Calls for Wider Warning On Low Testosterone Medication Labe

With over 100 Testosterone Treatment Lawsuits Pending Litigation, The FDA Continues Its Investigation Into The Potential Health Risks of Testosterone Replacement Therapy Drugs Reports Wright & Schulte LLC Columbus, OH (PRWEB) June 20, 2014 As testosterone treatment lawsuits move forward in federal litigation in Illinois, Wright & Schulte LLC has learned that the U.S. Food & Drug Administration (FDA) is now requiring manufacturers of testosterone therapy products to expand their drug labels to include a general warning about the risk of blood clots in veins. Wright & Schulte
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories